Category:

At the beginning of 2019, ...the…Food and Drug Administration began accepting pilot project proposals to identify solutions for meeting the 2023 requirements of the Drug Supply Chain and Security Act. The…Congress passed the DSCSA to improve the security of the pharmaceutical supply chain to help eliminate counterfeit pharmaceuticals and enhance patient safety...the MediLedger Project, a working group of 24 industry leading pharmaceutical manufacturers, distributors, retail chains, logistics partners and solution providers, was accepted by the FDA as one of their approved proposals…The working group’s purpose was to evaluate blockchain technology…in the track and trace of prescription medicines in the United States. The MediLedger Project released…the MediLedger DSCSA Pilot Project Final Report detailing how and why blockchain can meet the 2023 DSCSA requirements for an interoperable, confidential change of ownership system in the US pharmaceutical supply chain…READ MORE

At a time when people expect negative news in the generics industry — whether it is unabating competition, price deflation, product quality and recall issues, or product supply shortages — many generics firms are managing to thrive...Amidst this disruption, many players in the generics sector are counterpunching with innovative strategies, accelerating their efforts to pursue a diversified business model and focusing on significantly increasing their pipeline of products to include new therapeutic areas and new dosage forms. They also are developing and commercializing complex medicines and delivery systems that position their business for continued long-term growth...READ MORE

A project that began in 2016 through a partnership with Renown Health and the Desert Research Institute, Healthy Nevada has gained national attention for its approach to population health. The study involves harvesting DNA from a significant population, providing individuals with information on their health risks as well data to study population health issues and concerns. According to Dr. Anthony Slonim, president and CEO of Renown Health...“We hope to improve the health of the community,” explained Slonim. “We hope to provide individuals with improved understanding of their health and their healthcare risks so they can change their behavior. And, we hope that we can make our community, our state and, potentially, our nation healthier as a result of this data.”...READ MORE

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Christina Mattina, welcome to This Week in Managed Care from the Managed Markets News Network

Christina Mattina, welcome to This Week in Managed Care from the Managed Markets News Network

The 2019 novel coronavirus, named 2019-nCoV, continues to dominate headlines as more cases emerge in the United States. As of February 5, the CDC has confirmed 11 positive tests of the virus in US patients...READ MORE

Here is a roundup of the latest coronavirus-related news:

1. Pharmacists are running short on surgical masks due to coronavirus fears, according to a new survey.
2. FDA issues emergency use authorization (EUA) for the first 2019-nCoV diagnostic.
3. Gilead Sciences is donating its experimental antiviral drug remdesivir for clinical trials involving patients with coronavirus in China.
4. Department of Health and Human Services will collaborate with Regeneron to develop treatment.

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Christina Mattina, welcome to This Week in Managed Care from the Managed Markets News Network